Animal models for autoimmune demyelinating disorders of the nervous system

Raine, 1997 Compston, 1998 1998 Gold, 1997, T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms, Trends Neurosci., 20, 399, 10.1016/S0166-2236(97)01079-5 Hafler, 1996, TCR usage in human and experimental demyelinating disease, Immunol. Today, 17, 152, 10.1016/0167-5699(96)80611-6 Storch, 1998, Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology, Brain Pathol., 8, 681, 10.1111/j.1750-3639.1998.tb00194.x Kojima, 1994, Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia, J. Exp. Med., 180, 817, 10.1084/jem.180.3.817 Lafaille, 1994, High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice, Cell, 78, 399, 10.1016/0092-8674(94)90419-7 Hohlfeld, 1997, Biotechnological agents for the immunotherapy of multiple sclerosis – Principles, problems and perspectives, Brain, 120, 865, 10.1093/brain/120.5.865 Miller, 1996, Central nervous system remyelination clinical application of basic neuroscience principles, Brain Pathol., 6, 331, 10.1111/j.1750-3639.1996.tb00859.x